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1. Introduction 
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Clinical proteomics is a relatively young discipline, but it has developed considerably 
in the last ten years. Because its easy and non-invasive collection in large quantities- 
saliva seems to be an ideal diagnostic target. According to this salivary proteomics 
has proven its suitability as a reliable diagnostic method for HIV, arthritis, but also in 
early cancer detection over many years.  
An early diagnosis of cancerous diseases plays a key role in the fight against 
malignancies. But in spite of the great emphasis on oral squamous cancer 
prevention, novel technologies in the diagnostics and therapy, there are still more 
than 300,000 new cases registered each year. The prognosis is becoming poorer, 
and the mortality rate is increased 3-4-fold in the last four decade. This is in 
accordance with the fact, that oral squamous cell carcinoma can present a poor 
symptomatology over a long period, and the occurrence of non-specific symptoms, 
such as dysphagia, or pain in oral cavity are not emerging problems for the patients. 
The lateness of diagnosis of this disease results in worsening of the survival rate. 
The IARC data indicate that about 60% of oral malignancies develop in males and 
40% in females in Europe. The main predisponating factor in the development of 
cancer is smoking, and alcohol-consumption. The coexistence of these two 
etiological factors leads to a 15-fold incidence. Genetic conditions as well as personal 
sensitivity are also contributing factors. 
The correlation between type-2 diabetes and oral diseases were established as early 
as the 20th century. The occurrence of periodontal diseases, dental caries, stomatitis 
and glossitis is 2-3-fold higher than in patients suffering not from diabetes mellitus. 
Inflammation as a mediator of carcinogenesis is a well-known fact. Recent conducted 
epidemiological studies showed an increased incidence of oral premalignancies and 
lichen planus among diabetic patients in comparison with healthy subjects. 
The purpose of this study was to compare the proteomic profile of diabetic and 
healthy volunteers, focusing on OSCC-referring saliva biomarkers.  
  
3 
 
 
2. Aims of the study 
1. Are there any oral squamous cell carcinoma salivary biomarkers in the precancer 
state rype-2 diabetes? 
 
2.We also were interested in the question if there are any differences in the 
biomarker profile of the diabetic patients suffering from the disease for a longer time. 
 
3. Our aim was to develop a reliable and good reprocible investigation protcol which 
will be able to use in further examinations 
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3. Material and Methods 
Patients selection 
For this study 45 volunteers were selected, and divided in into 2 groups: patients 
suffering from type-2 diabetes, and the control group of healthy volunteers. Patient 
recruitment, sample collection and the follow-up were carried out by the examination 
team. The datas were recorded on a specially prepared questionnaire. Besides the 
relevant personal data, the recorded information of laboratory values, related to 
previous treatment, past medical history, as well as alcohol consumption and 
smoking habits were also recorded. This was followed by a total stomato-oncological 
screening examination. Patient exclusion criteria have been summarized in Table 1. 
1. Uncontrolled diabetes 
2. Cancer (benign or malignant), precancerous lesions 
3. Poor oral hygiene 
4. Psychiatric problems 
5. Active infection or inflammation in the oral cavity 
6. Rejecting the participation or the follow-up 
 
Table 1.: Summary of the exclusion criterias 
 
 
Between 4th January and 30th November 2012, the screenings were carried out on 45 
volunteers at the 2nd Department of Internal Medicine and Nephrology, University of 
Pecs, Hungary. A total of 45% were women and 55 % were men. The average age 
was: 62.3. The control group comprised 20 adults (10 women, 10 men), their mean 
age was: 61.2 years.  
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Sample collection 
All subjects were asked to attend the examination between 8 a.m. and 10 a.m., 
without having drink or food since the night before. First a complete stomato-
oncological examination was performed; details of state on of the teeth, 
periodontium, mucosal lesions, precanceroses were also recorded. This was followed 
by mouth rinsing with tap water. The whole, unstimulated saliva samples were 
collected with 5 ml sterile syringes using a special tactile-induced collection method, 
developed by our team. The collecting area involved the buccal and the lingual fold. 
The saliva specimens were cooled on ice; this was followed by centrifugation at 2500 
rpm for 12 min at 4°C. The supernatants of the saliva samples were stored frozen at -
80°C until further analysis.  
Proteomic methods 
1. Sodium Dodecylsulfate-Polyacrylamide Gel Electro phoresis (SDS-PAGE) 
Ultra Turrax homogenizer was used to homogenize the saliva samples in 20 mM 
Tris/HCL buffer (pH 7.4), containing 3 mM EDTA, 5 mM betamercaptoethanol and 
1% sodium-dodecylsulfate (SDS). This was followed by the addition of 1% 
bromphenolblue, and then the samples were boiled for 2 minutes and clarified by 
centrifugation (8000×g for 2 minutes). SDS-PAGE was carried out on 12% gel, using 
the Laemmli’s method. For estimating the molecular weight a low-molecular weight 
calibration kit (Pharmacia) was used. We stained the gels with Coomassie brilliant 
blue R-250 and the gels were destained with a solution of 5% (v/v) acetic acid and 
16% (v/v) methanol. 
 
2. Tryptic digestion and MALDI TOF/TOF mass spectrometry 
 
We excised the bands of interest with a scalpel blade, placed them in Eppendorf 
tubes and destained them by washing three times for 10 minutes in 200 µl of 50% 
(v/v) acetonitrile, 50 mM NH4HCO3 solution. Proteins were reduced with 20 mM 
dithiotreitol, 100 mM NH4HCO3 and 5% acetonitrile for 1 h at 55°C. The gel pieces 
were dehydrated at room temperature and covered with 10 µL of modified trypsin 
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(Promega, Madison, WI, USA; sequencing grade) (0.04 mg mL-1) in Tris buffer (2.5 
mM, pH 8.5) and left to stand at 37°C overninght. The spots were crushed and the 
peptides were extracted for 15 minutes in an ultrasonic bath with 15 µL of an 
aquenous solution of acetonitrile and formic acid (49/50/1 v/v/v). After extraction, the 
solution of the peptides was lyophilizied protein tryptic digests were purified by using 
ZipTip C18 solid-phase extraction (Millipore Kft., Budapest, Hungary) and directly 
loaded onto the target plate (MTP 384 massive target T, Bruker Daltonics, Bremen, 
Germany) by mixing 1.0 µL of each solution with the same volume of saturated 
matrix solution prepared fresh every day by dissolving a-cyano-4-hydroxicinnamic 
acid (CHCA) in acetonitrile/0.1% TFA (1/2, v/v). The mass-spectrometer used in this 
work was an Autoflex II TOF/TOF ( Bruker Daltonics, Bremen, Germany) operated in 
the reflector mode for MALDI TOF peptide mass fingerprint (PMF) or LIFT mode for 
post-source decay (PSD) and collision-induced decay (CID) MALDI TOF/TOF with an 
automated mode using FlexControl 2.4 software. An accelerating voltage of 20 kV 
was applied for PMF. The instrument uses a 337 nm pulsed nitrogen laser, model 
MNL-205MC (LBT Lasertechnik Berlin GmbH, Berlin, Germany). External calibration 
was performed in each case with a Bruker Peptide Calibration Standard (#206195 
Peptide Calibration Standard, Bruker Daltonics, Bremen, Germany). Peptide masses 
were acquired in the range m/z 800 to m/z 5000. Each spectrum was produced by 
accumulating date from 1000 consecutive laser shots.  
3. Identification of the peptide fragments 
Singly charged monoisotopic peptide masses were searched against Swiss-Prot and 
NCBInr databases utilizing the MASCOT Server 2.2 search engine 
(www.matrixscience.com, Matrix Science Ltd., London, UK) and Bruker BioTools 3.0 
software (Bruker Daltonics, Bremen, Germany). A maximum of one missed tryptic 
cleavage was considered and the mass tolerance for monoisotopic peptide masses 
was set to 100 ppm. For the proteins not identified by MALDI TOF, we proceeded 
with PSD and CID MALDI TOF/TOF analysis. Bruker FlexControl 2.4 software 
(Bruker Daltonics, Bremen, Germany) was used for the control of the instrument and 
Bruker FlexAnalysis 2.4 software (Bruker Daltonics, Bremen, Germany) for spectrum 
evaluation.  
4. Statistical analysis 
The statistical analysis was carried out by the ClinProTools 3.0 software, which is 
easy-to-use data post-processing software for visualization, data reduction, data 
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mining and building predictive models from protein profiling data using Bruker’s 
MALDI-TOF mass spectrometers. Supervised classification model generation and 
validation using different sophisticated mathematical and bioinformatic algorithms like 
t-probe or the Wilcoxon-test. ClinProTools combines intuitive visualization features 
and multiple mathematical algorithms to generate pattern recognition models for 
classification and prediction of e.g. disease from mass spectrometry based profiling 
data. ClinProTools uses a range of algorithms for generating classification models.  
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4. The Results 
Focusing on the potential carcinogenetic effect of diabetes we analyzed human 
saliva samples for detecting oral squamous cell carcinoma biomarkers. According to 
the comparing SDS- PAGE gel the protein content of the diabetic and healthy 
samples was different. The potentially oral squamous cell-related protein spots were 
excised and digested with trypsin. The resulting peptides were analyzed by MALDI 
TOF/TOF MS for protein indication. We could indentify over 900 peptides. There 
were also obvious differences in the amount of oral squamous cell carcinoma 
biomarkers. The differences in the spectras are marked in Figure 1.  
Figure 1.: Differences in the spectras. Picture A show the spectras in the saliva 
samples of a diabetic patient suffering from the disease over 18 years. All 3 
predictible biomarker are present. While on Picture B the saliva sample of a healthy 
subject shows none of the biomarkers. 
Picture A: Diabetic sample, biomarker spectras marked 
 
Picture B: Saliva sample of a healthy 58 years old women contain none of the typical 
biomarkers 
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Table 2. The list of the detected potential OSCC biomarkers 
Nr Name ID Code 
Theoretical 
weight (Da) 
    Sequence  
     covarage% 
1. Annexin A8-like 2 [Homo 
sapiens] 
gi|55666310 36,84 47,63 
2. 
Annexin A8-like 
Homo sapiens 
Q5T2P8_HUMAN 36,86 32,72 
3. Tyrosine kinase gi|473882 7,36 46,88 
4. 
AX969656 NID 
Homo sapiens 
CAF14764 14,82 26,61 
5. 
Protein kinase 
[Homo sapiens] 
gi|9886711 86,35 31,59 
6. Peroxiredoxin-2 gi|2507169 21,7 64 
7. Annexin A2 gi|113950 38,44 30 
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Table 3. Comparison of the OSCC biomarker profile of both groups. 1- Annexin A8, 
2-Peroxiredoxin 2, 3- Tirozin protein kinase 
Diabetes 
n=25 
Biomarker 
Control 
n=20 
Biomarker 
D001 1,2,3 H001 neg 
D002 1,2,3 H002 neg 
D003 1,3 H003 neg 
D004 1,2,3 H004 neg 
D005 1,2 H005 neg 
D006 1,2,3 H006 neg 
D007 1,2,3 H007 neg 
D008 1,2,3 H008 neg 
D009 1,2,3 H009 neg 
D010 1,2,3 H010 neg 
D011 1,3 H011 neg 
D012 1,2,3 H012 neg 
D013 1,2,3 H013 neg 
D014 1,2,3 H014 neg 
D015 1,3 H015 neg 
D016 1,2,3 H016 neg 
D017 1,2 H017 neg 
D018 1,2 H018 neg 
D019 1,2,3 H019 neg 
D020 1,2,3 H020 neg 
D021 1,2,3   
D022 1,2,3   
D023 1,2   
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D024 1,2,3   
D025 1,3   
  
Introducing the identified biomarkers 
Annexin A8 
Annexins are important in various cellular and physiological processes such as 
providing a membrane scaffold, which is relevant to changes in the cell's shape. Also, 
annexins have been shown to be involved in trafficking and organization of vesicles, 
exocytosis, endocytosis and also calcium ion channel formation. Annexins have also 
been found outside the cell in the extracellular space and have been linked to 
fibrinolysis, coagulation, inflammation and apoptosis. Annexins have many forms; 
Annexin A11 binds specifically to calcyclin in a calcium-dependent manner and is 
required for midbody formation and completion of the terminal phase of cytokinesis. 
According to this Annexin A11 and A8 is involved in cell growth and a reduction in 
annexin A11 expression using RNAi stops cell division. Annexins have been 
implicated in several disease processes, including inflammation and neoplasia. 
Alterations in the expression of individual annexins have been associated with 
tumorigenesis in several types of tumour. Loss of Annexin A1 has been found to be 
an early event in oesophageal squamous cell carcinoma. According to our study it 
may seem that an overexpression of Annexin A11 and A8 may not only related with 
colorectal cancer as described previously, but may be also an indicator for 
development of OSCC. 
Tyrosine protein kinase 
Tyrosine-specific protein kinases are enzymes which catalyze the addition of a 
phosphate group from tyrosine specific amino residues. These enzymes are key 
regulatory components in signal transduction, regulating cell division, cellular 
differentiation, and morphogenesis. A mutation that causes certain tyrosine kinases 
to be constitutively active has been previously associated with several cancers. Their 
exact role in the carcinogenesis and in the development of OSCC needs to be 
analyzed in more detail in our future investigations.  
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Peroxiredoxin 2 
The thioredoxin peroxidase family, the also called peroxiredoxins, efficiently reduces 
the intracellular level of H2O2 produced in those cells stimulated by various cell 
surface ligands. The peroxiredoxin family was reported to be closely related to 
various causes of liver fibrosis, and also of oral squamous cell carcinoma. The 
oxidation kinetics of all peroxiredoxin was extremely rapid and sensitive, occurring at 
H2O2 doses unable to affect common markers of cellular oxidative stress. In our 
research, Peroxiredoxin-2 has shown a significant up-regulation at patients, suffering 
longer time (up to 10 years) from type-2 diabetes, which indicated that it is an early 
protein target of OSCC. This result is summarized in table 4. 
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Table 4: Occurance of peroxiredoxin 2 in diabetic patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Code Gender 
Diagnosed with DM  
Since (years) 
D001 female 13 
D002 female 9 
D004 male 15 
D005 male 13 
D006 female 12 
D007 female 6 
D008 male 25 
D009 female 11 
D010 male 19 
D012 female 13 
D013 female 18 
D014 female 25 
D016 female 8 
D017 female 10 
D018 male 6 
D019 female 14 
D020 male 7 
D021 female 15 
D022 male 16 
D023 male 12 
D024 male 5 
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5. Discussion  
Previous epidemiological studies revealed that the incidence of benign tumors, 
leukoplakia and malignancies were 2-3 times higher than by the healthy control 
group. Accordingly, in this present study our aim was to identify several OSCC-
regulated salivary proteins as potential biomarkers. 
Biomarkers are important tools for cancer detection and monitoring. By 
understanding their role in cancer development, would improve the possibility of early 
detection of OSCC. The analysis of human saliva has become one of the most 
promising approaches. Saliva as a diagnostic fluid is widely used in the diagnostics of 
HIV, various forms of cancer, arthritis and much more.  
The main advantage of saliva is that the sample collection is non-invasive, safe and 
inexpensive. A major drawback to using saliva as a diagnostic fluid has been notion 
that informative analytes are present with lower amounts than in the serum. But over 
the past few years the development of proteomic technologies has made it possible 
to use saliva for detecting cancer markers.  
The great advantage of proteomics lies in the fact, that it is able to screen rapidly 
global and specific changes in gene expression that occur in the cancer cells. The 
mass-spectrometry driven analysis is potentially important tool for the rapid 
identification of specific biomarkers and proteomic patterns in the proteomes of body 
fluids. In this study we discovered specific OSCC-related biomarkers such as 
Peroxiredoxin-2, Annexin A8, Tyrosine kinase almost in all diabetic samples. An 
increased level of several common glucopeptides was also detected.  
In conclusion, this study has shown that an elevated level of Annexin A8, 
Peroxiredoxin-2 may seem to be correlated with the premalignant state type-2 
diabetes. Their role in the possible development of OSCC should not be 
underestimated.  
Our further plan is to investigate on these proteins, on larger population. But specific 
analyses and confirmations are required to validate their exact role in the 
pathogenesis of oral squamous cell carcinoma.  
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6. Novel findings 
1. In our study we could identify 3 salivary biomarkers in diabetic patients which are 
related and previously described in oral squamous cell carcinoma. Their exact role in 
the development of the disease needs further analysis, but according to our datas 
these biomarkers should be taken as predictible biomarkers of OSCC. 
2. Our study revealed that peroxiredoxin 2 occurs more often in patients suffering 
from type-2 diabetes for over 10 or more years.  
3. Our methods and investigation protocol is standardized and very good reprocible 
which could serve as a basis for the further investigations. 
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